 |
Previous Article | Next Article 
The Journal of Neuroscience, August 15, 1999, 19(16):7100-7110
Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular
Calcium and May Mediate ApoE Neurotoxicity
Martin
Tolar1,
Jeffrey N.
Keller2,
Stephen
Chan2,
Mark P.
Mattson2,
Marcos A.
Marques3, and
Keith A.
Crutcher1, 3
1 Department of Neurosurgery, University of Cincinnati
College of Medicine, Cincinnati, Ohio 45267, 2 Sanders-Brown Research Center on Aging and Department of
Anatomy and Neurobiology, University of Kentucky, Lexington, Kentucky
40536, and 3 ApoLogic, Inc., Cincinnati, Ohio 45219
Apolipoprotein E (apoE)-related synthetic peptides, the 22 kDa
N-terminal thrombin-cleavage fragment of apoE (truncated apoE), and
full-length apoE have all been shown to exhibit neurotoxic activity
under certain culture conditions. In the present study, protease
inhibitors reduced the neurotoxicity and proteolysis of full-length
apoE but did not block the toxicity of truncated apoE or a synthetic
apoE peptide, suggesting that fragments of apoE may account for its
toxicity. Additional experiments demonstrated that both truncated apoE
and the apoE peptide elicit an increase in intracellular calcium levels
and subsequent death of embryonic rat hippocampal neurons in culture.
Similar effects on calcium were found when the apoE peptide was applied
to chick sympathetic neurons. The rise in intracellular calcium and the
hippocampal cell death caused by the apoE peptide were significantly
reduced by receptor-associated protein, removal of extracellular
calcium, or administration of the specific NMDA glutamate receptor
antagonist MK-801. These results suggest that apoE may be a source of
both neurotoxicity and calcium influx that involves cell surface
receptors. Such findings strengthen the hypothesis that apoE plays a
direct role in the pathology of Alzheimer's disease.
Key words:
proteolysis; intracellular calcium; apolipoprotein E; neurotoxicity; LRP; degeneration; Alzheimer's disease
Copyright © 1999 Society for Neuroscience 0270-6474/99/19167100-11$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Q. Xu, D. Walker, A. Bernardo, J. Brodbeck, M. E. Balestra, and Y. Huang
Intron-3 Retention/Splicing Controls Neuronal Expression of Apolipoprotein E in the CNS
J. Neurosci.,
February 6, 2008;
28(6):
1452 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Stutzmann
The Pathogenesis of Alzheimers Disease Is It a Lifelong "Calciumopathy"?
Neuroscientist,
October 1, 2007;
13(5):
546 - 559.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S D. Han, A. I Drake, L. M Cessante, A. J Jak, W. S Houston, D. C Delis, J V. Filoteo, and M. W Bondi
Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism?
J. Neurol. Neurosurg. Psychiatry,
October 1, 2007;
78(10):
1103 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Mahley, K. H. Weisgraber, and Y. Huang
Inaugural Article: Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease
PNAS,
April 11, 2006;
103(15):
5644 - 5651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Smith, D I Graham, L S Murray, J Stewart, and J A R Nicoll
Association of APOE e4 and cerebrovascular pathology in traumatic brain injury.
J. Neurol. Neurosurg. Psychiatry,
March 1, 2006;
77(3):
363 - 366.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Gay, R. C. Klein, and J. L. Yakel
Apolipoprotein E-Derived Peptides Block {alpha}7 Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes
J. Pharmacol. Exp. Ther.,
February 1, 2006;
316(2):
835 - 842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Huang
Apolipoprotein E and Alzheimer disease
Neurology,
January 24, 2006;
66(1_suppl_1):
S79 - S85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chang, T. r. Ma, R. D. Miranda, M. E. Balestra, R. W. Mahley, and Y. Huang
Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity
PNAS,
December 20, 2005;
102(51):
18694 - 18699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Farkas, K. H. Weisgraber, V. L. Shepherd, M. F. Linton, S. Fazio, and L. L. Swift
The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways
J. Lipid Res.,
August 1, 2004;
45(8):
1546 - 1554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber
Androgens, ApoE, and Alzheimer's Disease
Sci. Aging Knowl. Environ.,
March 17, 2004;
2004(11):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Brecht, F. M. Harris, S. Chang, I. Tesseur, G.-Q. Yu, Q. Xu, J. Dee Fish, T. Wyss-Coray, M. Buttini, L. Mucke, et al.
Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice
J. Neurosci.,
March 10, 2004;
24(10):
2527 - 2534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Suo, M. Wu, B. A. Citron, R. E. Palazzo, and B. W. Festoff
Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling
J. Biol. Chem.,
September 26, 2003;
278(39):
37681 - 37689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Harris, W. J. Brecht, Q. Xu, I. Tesseur, L. Kekonius, T. Wyss-Coray, J. D. Fish, E. Masliah, P. C. Hopkins, K. Scearce-Levie, et al.
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
PNAS,
September 16, 2003;
100(19):
10966 - 10971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Buttini, G.-Q. Yu, K. Shockley, Y. Huang, B. Jones, E. Masliah, M. Mallory, T. Yeo, F. M. Longo, and L. Mucke
Modulation of Alzheimer-Like Synaptic and Cholinergic Deficits in Transgenic Mice by Human Apolipoprotein E Depends on Isoform , Aging, and Overexpression of Amyloid beta Peptides But Not on Plaque Formation
J. Neurosci.,
December 15, 2002;
22(24):
10539 - 10548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimoto, H. Jiang, T. Niikura, Y. Ito, A. Hagiwara, K. Umezawa, Y. Abe, Y. Murayama, and I. Nishimoto
Neuronal Apoptosis by Apolipoprotein E4 through Low-Density Lipoprotein Receptor-Related Protein and Heterotrimeric GTPases
J. Neurosci.,
November 15, 2000;
20(22):
8401 - 8409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Bacskai, M. Q. Xia, D. K. Strickland, G. W. Rebeck, and B. T. Hyman
The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors
PNAS,
September 29, 2000;
(2000)
200238297.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Ohkubo, N. Mitsuda, M. Tamatani, A. Yamaguchi, Y.-D. Lee, T. Ogihara, M. P. Vitek, and M. Tohyama
Apolipoprotein E4 Stimulates cAMP Response Element-binding Protein Transcriptional Activity through the Extracellular Signal-regulated Kinase Pathway
J. Biol. Chem.,
January 26, 2001;
276(5):
3046 - 3053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Bacskai, M. Q. Xia, D. K. Strickland, G. W. Rebeck, and B. T. Hyman
The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors
PNAS,
October 10, 2000;
97(21):
11551 - 11556.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|